Revenue from operations jumped 18.5% to Rs 398.08 crore in the quarter ended 31 December 2024. Total expenses rose by 22% YoY to Rs 317.03 crore in the third quarter. Cost of materials consumed stood at Rs 53.73 crore (up 25.8% YoY), employee benefit expense was at Rs 49.31 crore (up 13.5% YoY) and finance cost stood at Rs 18.07 crore (up 26.7% YoY) during the period under review. Profit before tax for the quarter stood at Rs 94.33 crore, up 11.3% from Rs 84.77 crore in the same quarter last year. For Q3 FY25, EBITDA grew 13.8% YoY to Rs 134.36 crore and EBITDA margin reduced to 33.8% from 35.1% posted in Q3 FY24. For the December 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 53.2% (up 244 bps YoY). Average revenue per occupied bed (ARPOB) was Rs 53,404 (down 4% YoY) and average length of stay (ALOS) was 2.91 days (up 11% YoY) during the period under review. On the operational front, the regional hub hospital in Rajahmundry, which has around 100 beds, is nearing completion and is expected to commence operations by Q1 FY26. Rainbow Children's Hospital continues to maintain a robust balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 6,669 million as of 31 December 2024. These funds will support our ongoing capital expenditure merger and acquisition plans. With our current cash and anticipated internal accruals in coming quarters, we are well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds. During the quarter, the company had invested Rs 218.3 million in capital expenditures towards expanding and enhancing our services at existing hospitals Dr. Ramesh Kancharla, chairman & managing director, said, 'I'm pleased to share that we had a strong performance this quarter. With a network of over 2,000 beds, including managed facilities, we strike the perfect balance between established and new hospitals. Our focus is on boosting occupancy, optimizing operations, and providing exceptional experiences for our patients. Looking ahead, we're confident in our continued growth and success in the coming quarters.' Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 5 clinics in 6 cities with a total bed capacity of 1,935 beds. The scrip slipped 2.60% to Rs 1,347.05 on the BSE. Powered by Capital Market - Live

Net profit of Rainbow Children's Medicare rose 10.56% to Rs 68.69 crore in the quarter ended December 2024 as against Rs 62.13 crore during the previous quarter ended December 2023. Sales rose 18.49% to Rs 398.08 crore in the quarter ended December 2024 as against Rs 335.96 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales398.08335.96 18 OPM %33.7535.15 - PBDT129.56112.43 15 PBT94.3384.77 11 NP68.6962.13 11 Powered by Capital Market - Live

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 9 February 2025.Powered by Capital Market - Live

Total expenses rose by 26.69% YoY to Rs 323.38 crore in the second quarter, primarily due to higher cost of materials consumed (up 22.32% YoY), employee benefit expense (up 31.94% YoY), higher finance cost (up 35.78% YoY) and higher professional fees to doctor (up 19.80% YoY). Profit before tax for the quarter stood at Rs 105.35 crore, up by 23.57% from Rs 85.25 crore in same quarter last year. For Q2 FY25, EBITDA grew 25.11% YoY to Rs 147.08 crore and EBITDA margin reduced to 35.2% from 35.3% posted in Q2 FY24. For the September 2024 quarter, capacity beds were at 1,935 units (up 16.9% YoY), operational bed count was 1,523 units (up 18.1% YoY) and occupancy rate was 59.9% (up 844 bps YoY). Average revenue per occupied bed (ARPOB) was Rs 49,770 (down 8.7% YoY) and average length of stay (ALOS) was 2.94 days (up 12.6% YoY) during the period under review. On the operational front, the company has signed a lease deed, for a brownfield spoke hospital to accommodate 90-beds in a rapidly growing micro market of Electronic City, Bengaluru and expect the hospital to commence operations, post interior works, by Q3 FY26. This will further strengthen Rainbow's hub and spoke model in Bengaluru. The firm continues to maintain a robust balance sheet, with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 5,814 million as of 30 September 2024. These funds will support its ongoing capital expenditure plans. With its current cash and anticipated internal accruals in the coming quarters, it is well-positioned to complete all planned capital expenditures using internal resources and the balance of IPO funds. During the quarter, the company had invested Rs 234 million in capital expenditures towards expanding and enhancing our services at existing hospitals. Dr. Ramesh Kancharla, chairman & managing director, said, 'I am delighted to share that we have delivered a strong performance this quarter led by robust volume growth across all hospitals. We currently have 2000+ beds, including the managed beds, with a right mix of matured and new beds. Our focus remains to drive occupancies and optimize operations across the group along with customer delight. We are confident in our ability to maintain the growth momentum in the upcoming quarters.' Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 4 clinics in 6 cities, with a total bed capacity of 1,935 beds. Powered by Capital Market - Live

Net profit of Rainbow Children's Medicare rose 25.37% to Rs 78.87 crore in the quarter ended September 2024 as against Rs 62.91 crore during the previous quarter ended September 2023. Sales rose 25.48% to Rs 417.46 crore in the quarter ended September 2024 as against Rs 332.68 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales417.46332.68 25 OPM %35.2335.34 - PBDT140.25112.05 25 PBT105.3585.25 24 NP78.8762.91 25 Powered by Capital Market - Live

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 27 October 2024.Powered by Capital Market - Live

Rainbow Childrens Medicare has allotted 5,986 equity shares under ESOP on 22 August 2024. With this allotment, the paid up equity share capital of the company has increased to 10,15,51,673 equity shares of Rs 10 each. Powered by Capital Market - Live

Revenue from operations increased 15% year on year (YoY) to Rs 330.22 crore in the quarter ended 30 June 2024. Total expenses rose by 20.64% YoY to Rs 288.79 crore in the first quarter, primarily due to higher cost of materials consumed (up 10.63% YoY), employee benefit expense (up 12.39% YoY), higher finance cost (up 24.3% YoY) and higher professional fees to doctor (up 21.65% YoY). Profit before tax for the quarter stood at Rs 53.35 crore, down by 4.08% from Rs 55.62 crore in same quarter last year. For Q1 FY25, EBITDA grew 6.9% YoY to Rs 93.72 crore and EBITDA margin reduced to 28.4% from 30.5% posted in Q1 FY24. For the June 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 42.4% (up 151 bps YoY). Average revenue per occupied bed (ARPOB) was Rs 56,212 (down 6% YoY) and average length of stay (ALOS) was 2.76 days (up 11% YoY) during the period under review. On the operational front, the company achieved a robust 15% revenue growth, reflecting our successful operational strategies and market positioning. Despite the traditionally slower summer period, our performance underscores the strength and resilience of our business model. While EBITDA growth was moderated due to the initial costs associated with our new facilities, we are confident in the long-term value of these investments. The firm continued to maintain a robust balance sheet and have cash & cash equivalent, fixed deposits and mutual fund investments aggregating to Rs 518 crore as of 30 June 2024. These funds will support ongoing capital expenditure plans. With the current cash flow and anticipated internal accruals in coming quarters, the company is well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds. During the quarter, the company invested Rs 56.7 crore in capital expenditures towards expanding and enhancing our facilities. Dr. Ramesh Kancharla, chairman & managing director, said, 'I am delighted to share that we have delivered a strong performance this quarter. Although our PAT for Q1 FY25 was Rs. 397 Mn, a decrease of 4.2% from Rs. 415 Mn in Q1 FY24, this is attributable to the initial costs associated with our new hospitals. We currently have 2000+ beds including the managed beds, with a right mix of matured and new beds. Our focus remains to drive occupancies and optimize operations across the group along with custromer delight. We are confident in our ability to drive growth in the upcoming quarters.' Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 4 clinics in 6 cities, with a total bed capacity of 1,935 beds. The scrip rose 1.61% to currently trade at Rs 1,222.40 on the BSE. Powered by Capital Market - Live

Net profit of Rainbow Children's Medicare declined 3.59% to Rs 39.53 crore in the quarter ended June 2024 as against Rs 41.00 crore during the previous quarter ended June 2023. Sales rose 14.99% to Rs 330.22 crore in the quarter ended June 2024 as against Rs 287.17 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales330.22287.17 15 OPM %28.3830.54 - PBDT87.5080.95 8 PBT53.3555.62 -4 NP39.5341.00 -4 Powered by Capital Market - Live

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live